Literature DB >> 18940302

Comparison of clinical features of arrhythmogenic right ventricular cardiomyopathy in men versus women.

Barbara Bauce1, Gianfranco Frigo, Frank I Marcus, Cristina Basso, Alessandra Rampazzo, Francesco Maddalena, Domenico Corrado, Mikolaj Winnicki, Luciano Daliento, Ilaria Rigato, Alexandros Steriotis, Elisa Mazzotti, Gaetano Thiene, Andrea Nava.   

Abstract

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heart muscle disease characterized by myocardial necrosis followed by fibrous-fatty replacement. The pathologic process constitutes the basis for ventricular arrhythmias due to re-entrant circuits. Even if this genetic disease is transmitted in the majority of cases with autosomal dominant trait, in all reported series ARVC is prevalent in men. In this study we investigate the impact that gender may have on clinical presentation in a large series of patients with ARVC. A total of 171 consecutive patients (mean 29 +/- 12 years, range 13 to 65) affected by ARVC were examined with family and personal history, 12-lead electrocardiogram (ECG), 24-hour ECG, signal-averaged ECG, and echocardiogram. Moreover, electrophysiological study and ventricular angiography were performed in selected cases. In the 171 subjects, 71% were men and 29% women (p = 0.02). No gender differences were found considering the age at the time of diagnosis and of study enrolment and the prevalence of index cases and family members. The genders differed in prevalence of abnormal ECG (69% vs 52%, p = 0.036) and presence of late potentials (60% vs 40%, p = 0.01). Moreover, men had larger right ventricular dimensions and practiced competitive sports more frequently (26% vs 14%, p <0.001). Nonetheless, gender was not associated with a high incidence of life-threatening ventricular arrhythmias or with a poor outcome. In conclusion, our data show that diagnosis of ARVC is less common in female patients, who present a higher prevalence of mild forms. Nonetheless, the degree of electrical instability does not differ significantly between genders in affected subjects. Even if ARVC remains mainly a male disease, gender does not have a role in patients' outcome. The cause of the under-representation of women is not clear, even if potentially important factors such as sexual hormones and physical activity could play a role.

Entities:  

Mesh:

Year:  2008        PMID: 18940302     DOI: 10.1016/j.amjcard.2008.06.054

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  23 in total

Review 1.  Evolving Approaches to Genetic Evaluation of Specific Cardiomyopathies.

Authors:  Loon Yee Louis Teo; Rocio T Moran; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2015-12

2.  Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies.

Authors:  Ali J Marian; Babken Asatryan; Xander H T Wehrens
Journal:  Cardiovasc Res       Date:  2020-07-15       Impact factor: 10.787

Review 3.  Arrhythmogenic right ventricular cardiomyopathy: an update on pathophysiology, genetics, diagnosis, and risk stratification.

Authors:  M Paul; T Wichter; L Fabritz; J Waltenberger; E Schulze-Bahr; P Kirchhof
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-09-26

4.  Arrhythmogenic Cardiomyopathy: Electrical and Structural Phenotypes.

Authors:  Deniz Akdis; Corinna Brunckhorst; Firat Duru; Ardan M Saguner
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-08

5.  Arrhythmogenic Right Ventricular Cardiomyopathy - 4 Swedish families with an associated PKP2 c.2146-1G>C variant.

Authors:  Anneli Svensson; Meriam Åström-Aneq; Kjerstin Ferm Widlund; Christina Fluur; Anna Green; Malin Rehnberg; Cecilia Gunnarsson
Journal:  Am J Cardiovasc Dis       Date:  2016-05-18

Review 6.  Arrhythmogenic Right Ventricular Cardiomyopathy: Risk Stratification and Indications for Defibrillator Therapy.

Authors:  Alessandro Zorzi; Ilaria Rigato; Barbara Bauce; Kalliopi Pilichou; Cristina Basso; Gaetano Thiene; Sabino Iliceto; Domenico Corrado
Journal:  Curr Cardiol Rep       Date:  2016-06       Impact factor: 2.931

7.  Clinical Presentation and Outcomes by Sex in Arrhythmogenic Right Ventricular Cardiomyopathy: Findings from the North American ARVC Registry.

Authors:  Naila Choudhary; Christine Tompkins; Bronislava Polonsky; Scott McNitt; Hugh Calkins; N A Mark Estes; Andrew D Krahn; Mark S Link; Frank I Marcus; Jeffrey A Towbin; Wojciech Zareba
Journal:  J Cardiovasc Electrophysiol       Date:  2016-03-21

8.  Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome.

Authors:  Deniz Akdis; Ardan M Saguner; Khooshbu Shah; Chuanyu Wei; Argelia Medeiros-Domingo; Arnold von Eckardstein; Thomas F Lüscher; Corinna Brunckhorst; H S Vincent Chen; Firat Duru
Journal:  Eur Heart J       Date:  2017-05-14       Impact factor: 29.983

Review 9.  Pathophysiology of arrhythmogenic cardiomyopathy.

Authors:  Cristina Basso; Barbara Bauce; Domenico Corrado; Gaetano Thiene
Journal:  Nat Rev Cardiol       Date:  2011-11-29       Impact factor: 32.419

Review 10.  Testosterone, cardiomyopathies, and heart failure: a narrative review.

Authors:  Rodica Diaconu; Ionuţ Donoiu; Oana Mirea; Tudor Adrian Bălşeanu
Journal:  Asian J Androl       Date:  2021 Jul-Aug       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.